Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

Forschungsstelle

INNOSUISSE

Projektnummer

102.774 IP-LS

Projekttitel

Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

Projekttitel Englisch

Targeting immunosenescence post cancer by boosting metabolic health (Innolink: 102.774 IP-LS)

Texte zu diesem Projekt

	Deutsch	Französisch	Italienisch	Englisch
Schlüsselwörter	-	-	-
Abstract	-	-	-

Kategorie	Text
Schlüsselwörter (Englisch)	Life sciences, Foodtech
Abstract (Englisch)	Amazentis has discovered a novel nutrient that improves immune function by boosting mitochondrial health. These findings are applicable for cancer survivors with a weak immune system. A study with leading oncologists at CHUV is proposed to translate and commercialize an advanced nutrition product.